Total Payments
$3,250
2024 Payments
$315.12
Companies
31
Transactions
136
Medicare Patients
4,349
Medicare Billing
$327,918
Payment Breakdown by Category
Food & Beverage$3,048 (93.8%)
Education$201.72 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,048 | 130 | 93.8% |
| Education | $201.72 | 6 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $793.57 | 24 | $0 (2024) |
| PFIZER INC. | $255.28 | 25 | $0 (2024) |
| Boston Scientific Corporation | $232.25 | 7 | $0 (2022) |
| Janssen Biotech, Inc. | $226.01 | 12 | $0 (2023) |
| Teleflex LLC | $188.25 | 5 | $0 (2023) |
| Coloplast Corp | $186.86 | 7 | $0 (2023) |
| Intuitive Surgical, Inc. | $160.55 | 1 | $0 (2017) |
| ABBVIE INC. | $137.02 | 9 | $0 (2024) |
| Innovation Technologies Inc | $116.02 | 1 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $99.28 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.12 | 9 | Astellas Pharma US Inc ($174.91) |
| 2023 | $335.18 | 8 | Innovation Technologies Inc ($116.02) |
| 2022 | $484.93 | 14 | Astellas Pharma US Inc ($142.19) |
| 2021 | $330.26 | 14 | Teleflex LLC ($162.40) |
| 2020 | $144.92 | 7 | C. R. Bard, Inc. & Subsidiaries ($41.27) |
| 2019 | $509.93 | 35 | PFIZER INC. ($221.22) |
| 2018 | $301.16 | 16 | NeoTract Inc. ($77.22) |
| 2017 | $828.41 | 33 | Astellas Pharma US Inc ($189.48) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/12/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/18/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| 05/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Oncology | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: Oncology | ||||||
| 02/23/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Oncology | ||||||
| 01/25/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $24.45 | General |
| 01/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/12/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Interventional Urology | ||||||
| 09/29/2023 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $23.01 | General |
| 06/14/2023 | Coloplast Corp | — | Food and Beverage | In-kind items and services | $93.66 | General |
| 06/05/2023 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/09/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Urology | ||||||
| 05/05/2023 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| 02/22/2023 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $116.02 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 01/13/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Oncology | ||||||
| 12/19/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $39.56 | General |
| 11/07/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Urology | ||||||
| 09/21/2022 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $79.63 | General |
| Category: Urology | ||||||
| 08/31/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/04/2022 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: CONTINENCE CARE | ||||||
| 08/01/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 07/18/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/29/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 552 | 761 | $141,893 | $35,096 |
| 2022 | 24 | 1,338 | 2,157 | $315,874 | $94,732 |
| 2021 | 25 | 1,285 | 2,895 | $514,455 | $122,265 |
| 2020 | 15 | 1,174 | 1,639 | $735,031 | $75,825 |
Total Patients
4,349
Total Services
7,452
Medicare Billing
$327,918
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 178 | $41,913 | $10,841 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $44,466 | $10,260 | 23.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 36 | 38 | $23,805 | $6,034 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 64 | $21,633 | $5,317 | 24.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 11 | 11 | $5,178 | $1,161 | 22.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 70 | 89 | $2,417 | $660.96 | 27.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 145 | 219 | $1,310 | $481.80 | 36.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 24 | $880.96 | $261.36 | 29.7% |
| J3260 | Injection, tobramycin sulfate, up to 80 mg | Office | 2023 | 11 | 38 | $290.57 | $78.29 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 271 | $73,032 | $16,844 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 130 | 130 | $64,463 | $14,330 | 22.2% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 24 | 390 | $20,530 | $13,635 | 66.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 61 | 63 | $43,727 | $12,001 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 101 | $38,660 | $9,225 | 23.9% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 21 | 78 | $8,213 | $5,461 | 66.5% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 15 | 15 | $11,126 | $2,214 | 19.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $10,600 | $2,133 | 20.1% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 24 | 60 | $3,158 | $2,098 | 66.4% |
| 87529 | Detection test by nucleic acid for herpes simplex virus, amplified probe technique | Office | 2022 | 24 | 60 | $3,158 | $2,098 | 66.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 19 | 19 | $7,779 | $2,096 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 44 | $7,276 | $1,705 | 23.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 170 | 190 | $5,654 | $1,391 | 24.6% |
| 87493 | Detection test by nucleic acid for clostridium difficile, amplified probe technique | Office | 2022 | 24 | 30 | $1,677 | $1,114 | 66.4% |
| 87496 | Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique | Office | 2022 | 24 | 30 | $1,579 | $1,049 | 66.4% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2022 | 24 | 30 | $1,579 | $1,049 | 66.4% |
About Dr. James Siefer, DO
Dr. James Siefer, DO is a Urology healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508846627.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Siefer, DO has received a total of $3,250 in payments from pharmaceutical and medical device companies, with $315.12 received in 2024. These payments were reported across 136 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,048).
As a Medicare-enrolled provider, Siefer has provided services to 4,349 Medicare beneficiaries, totaling 7,452 services with total Medicare billing of $327,918. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Chandler, AZ
- Active Since 01/17/2006
- Last Updated 06/07/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1508846627
Products in Payments
- XTANDI (Drug) $426.49
- Xtandi (Drug) $312.99
- UroLift System (Device) $162.40
- Da Vinci Surgical System (Device) $160.55
- ZYTIGA (Drug) $160.07
- IRRISEPT (Device) $116.02
- LithoVue (Device) $114.35
- PROVENGE (Drug) $99.28
- Myrbetriq (Drug) $97.31
- MYRBETRIQ (Drug) $85.30
- Androgel (Drug) $82.43
- AQUABEAM ROBOTIC SYSTEM (Device) $79.63
- UroLift (Device) $77.22
- XIAFLEX (Biological) $49.19
- BMD-Magic3 Catheter (Device) $47.07
- PYLARIFY (Drug) $46.44
- TOVIAZ (Drug) $43.19
- GENTLECATH (Device) $42.10
- SPEEDICATH (Device) $41.17
- Nubeqa (Drug) $38.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.